F-group (family)
207.1.1.55 LRR_1,LRR_8
Ligands and drugs
1,492
Member domains
320
with ligand contacts (≤ 4 Å)
21.4% of members
276
with DrugDomain annotations
18.5% of members
266
with a DrugBank compound
17.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 207.1.1.55 belongs to X-group 207 Single-stranded right-handed beta-helix, which binds 6.1 ligand superclasses per 20 proteins, narrower than 73% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 247 |
| DB02745 | URI | Uridine | 23 |
| DB06530 | RX8 | Resiquimod | 13 |
| DB08231 | MYR | Myristic acid | 4 |
| DB16501 | QLH | Enpatoran | 4 |
| DB00724 | 6T0 | Imiquimod | 3 |
| DB02857 | GMP | Guanosine | 3 |
| DB02767 | FTT | (R)-3-hydroxytetradecanoic acid | 2 |
| DB03548 | KDO | 3-deoxy-alpha-D-manno-oct-2-ulopyranosonic acid | 2 |
| DB09130 | — | — | 2 |
| DB12687 | 9JR | Vesatolimod | 2 |
| DB01593 | — | — | 1 |
| DB03175 | POL | Propyl alcohol | 1 |
| DB03796 | PLM | Palmitic Acid | 1 |
| DB14487 | — | — | 1 |
| DB14533 | — | — | 1 |
| DB16324 | — | — | 1 |
| DB16580 | — | — | 1 |
| DB17589 | SDL | Loxoribine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 278 |
| URI | URIDINE | 25 |
| UCG | 3'-O-[(R)-{[(2R,3aR,4R,6R,6aR)-6-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-2-hydroxy-2-oxidotetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-4-yl]methoxy}(hydroxy)phosphoryl]uridine 5'-(dihydrogen phosphate) | 16 |
| RX8 | 1-[4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol | 15 |
| IDQ | 1-[[4-(aminomethyl)phenyl]methyl]-2-butyl-imidazo[4,5-c]quinolin-4-amine | 11 |
| GP4 | 2-amino-2-deoxy-4-O-phosphono-alpha-D-glucopyranose | 10 |
| 06S | O-[(2R,3S,4R,5R)-5-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-2-({[(S)-({(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-hydroxy-2-[(thiophosphonooxy)methyl]tetrahydrofuran-3-yl}oxy)(sulfanyl)phosphoryl]oxy}methyl)-4-hydroxytetrahydrofuran-3-yl] dihydrogen (S)-phosphorothioate | 8 |
| M4D | 5-(4-azanylbutyl)-3-pentyl-quinolin-2-amine | 8 |
| MBL | 1-pentyl-4-phenyl-imidazol-2-amine | 8 |
| U57 | (2R)-2-[(2-amino-7-fluoropyrido[3,2-d]pyrimidin-4-yl)amino]-2-methylhexan-1-ol | 8 |
| UPT | 1-[(2R,3aR,4R,6R,6aR)-2-hydroxy-6-(hydroxymethyl)-2-sulfidotetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-4-yl]pyrimidine-2,4(1H,3H)-dione | 8 |
| CL | CHLORIDE ION | 7 |
| C09 | 2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-4-amine | 6 |
| CAmetal | CALCIUM ION | 6 |
| JRI | (2R,6R)-4-(8-cyanoquinolin-5-yl)-N-[(3S,4R)-4-fluoranylpyrrolidin-3-yl]-6-methyl-morpholine-2-carboxamide | 6 |
| L07 | 2-propyl[1,3]thiazolo[4,5-c]quinolin-4-amine | 6 |
| MGmetal | MAGNESIUM ION | 5 |
| 0IL | (3R)-3-(tetradecanoyloxy)tetradecanoic acid | 4 |
| 7VC | 4-(7-methoxyquinolin-4-yl)-2-methyl-phenol | 4 |
| 7VF | 4-(3-methyl-4-oxidanyl-phenyl)quinolin-7-ol | 4 |